The Oncosearch | Oncotarget

PHLDA2 is a key oncogene-induced negative feedback inhibitor of EGFR/ErbB2 signaling via interference with AKT signaling Research Paper

Xiaoqi Wang, Guangyuan Li, Sanjay Koul, Rieko Ohki, Matthew Maurer, Alain Borczuk, Balazs Halmos

Published May 18, 2018 · Vol. 9, No. 38 · pp. 24914-24926

Aberration hubs in protein interaction networks highlight actionable targets in cancer Research Paper

Mehran Karimzadeh, Pouria Jandaghi, Andreas I. Papadakis, Sebastian Trainor, Johan Rung, Mar GonzÃ lez-Porta, Ghislaine Scelo, Naveen S. Vasudev, Alvis Brazma, Sidong Huang, Rosamonde E. Banks, Mark Lathrop, Hamed S. Najafabadi, Yasser Riazalhosseini

Published May 18, 2018 · Vol. 9, No. 38 · pp. 25166-25180

High salt induces P-glycoprotein mediated treatment resistance in breast cancer cells through store operated calcium influx Research Paper

Duaa Babaer, Suneetha Amara, Michael Ivy, Yan Zhao, Philip E. Lammers, Jens M. Titze, Venkataswarup Tiriveedhi

Published May 18, 2018 · Vol. 9, No. 38 · pp. 25193-25205

Large set data mining reveals overexpressed GPCRs in prostate and breast cancer: potential for active targeting with engineered anti-cancer nanomedicines Research Paper

Eric KÃ¼bler, Hugo Albrecht

Published May 18, 2018 · Vol. 9, No. 38 · pp. 24882-24897

Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer Research Paper

Yekaterina Y. Zaytseva, Piotr G. Rychahou, Anh-Thu Le, Timothy L. Scott, Robert M. Flight, Ji Tae Kim, Jennifer Harris, Jinpeng Liu, Chi Wang, Andrew J. Morris, Theru A. Sivakumaran, Teresa Fan, Hunter Moseley, Tianyan Gao, Eun Y. Lee, Heidi L. Weiss, Timothy S. Heuer, George Kemble, Mark Evers

Published May 15, 2018 · Vol. 9, No. 37 · pp. 24787-24800

Combined mTOR and MEK inhibition is an effective therapy in a novel mouse model for angiosarcoma Research Paper

Michelle L. Chadwick, Adam Lane, Dana Thomas, Amanda R. Smith, Angela R. White, Dominique Davidson, Yuxin Feng, Elisa Boscolo, Yi Zheng, Denise M. Adams, Anita Gupta, AndrÃ© Veillette, Lionel M.L. Chow

Published May 15, 2018 · Vol. 9, No. 37 · pp. 24750-24765

Potentiation of ¹⁷⁷Lu-octreotate peptide receptor radionuclide therapy of human neuroendocrine tumor cells by PARP inhibitor Research Paper

Nupur K. Purohit, Rashmi G. Shah, Samuel Adant, Michael Hoepfner, Girish M. Shah, Jean-Mathieu Beauregard

Published May 15, 2018 · Vol. 9, No. 37 · pp. 24693-24706

Regulatory role of resveratrol, a microRNA-controlling compound, in HNRNPA1 expression, which is associated with poor prognosis in breast cancer Research Paper

Kurataka Otsuka, Yusuke Yamamoto, Takahiro Ochiya

Published May 15, 2018 · Vol. 9, No. 37 · pp. 24718-24730

⁸⁹Zr-labeled CEA-targeted IL-2 variant immunocytokine in patients with solid tumors: CEA-mediated tumor accumulation and role of IL-2 receptor-binding Research Paper

Emilie M.J. van Brummelen, Marc C. Huisman, Linda J. de Wit-van der Veen, Tapan K. Nayak, Marcel P.M. Stokkel, Emma R. Mulder, Otto S. Hoekstra, Danielle J. Vugts, Guus A.M.S. Van Dongen, Henk M. Verheul, Stefan Evers, Jean J.L. Tessier, Jose Saro, Jan H.M. Schellens, C. Willemien Menke-van der Houven van Oordt

Published May 15, 2018 · Vol. 9, No. 37 · pp. 24737-24749

A novel liver metastasis-correlated protein of pancreatic neuroendocrine neoplasm (PanNEN) discovered by proteomic analysis Research Paper

Mitsuhiro Shimura, Masamichi Mizuma, Tatsuyuki Takadate, Yasutake Katoh, Takashi Suzuki, Masahiro Iseki, Tatsuo Hata, Shuichi Aoki, Yukie Suzuki, Naoaki Sakata, Hideo Ohtsuka, Hiroki Hayashi, Takanori Morikawa, Kei Nakagawa, Fuyuhiko Motoi, Takeshi Naitoh, Kazuhiko Igarashi, Hironobu Sasano, Michiaki Unno

Published May 11, 2018 · Vol. 9, No. 36 · pp. 24291-24303

Pivotal role of human stearoyl-CoA desaturases (SCD1 and 5) in breast cancer progression: oleic acid-based effect of SCD1 on cell migration and a novel pro-cell survival role for SCD5 Research Paper

Cristiana Angelucci, Alessio Dâ€™Alessio, Fortunata Iacopino, Gabriella Proietti, Alba Di Leone, Riccardo Masetti, Gigliola Sica

Published May 11, 2018 · Vol. 9, No. 36 · pp. 24364-24380

Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancer Research Paper

Ernest S. Han, Wei Wen, Thanh H. Dellinger, Jun Wu, Selena A. Lu, Richard Jove, John H. Yim

Published May 11, 2018 · Vol. 9, No. 36 · pp. 24304-24319

Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma Research Paper

Xiuhui Shi, Yan Zhao, Ruizhi He, Min Zhou, Shutao Pan, Shuo Yu, Yu Xie, Xu Li, Min Wang, Xingjun Guo, Renyi Qin

Published May 11, 2018 · Vol. 9, No. 36 · pp. 24248-24259

Apatinib as targeted therapy for sarcoma Review

Feng Li, Zhichao Liao, Chao Zhang, Jun Zhao, Ruwei Xing, Sheng Teng, Jin Zhang, Yun Yang, Jilong Yang

Published May 11, 2018 · Vol. 9, No. 36 · pp. 24548-24560

Genome-wide multi-omics profiling of the 8p11-p12 amplicon in breast carcinoma Research Paper

Toshima Z. Parris, Elisabeth Werner RÃ¶nnerman, Hanna Engqvist, Jana Biermann, Katarina TruvÃ©, SzilÃ¡rd Nemes, Eva Forssell-Aronsson, Giovanni Solinas, AnikÃ³ KovÃ¡cs, Per Karlsson, Khalil Helou

Published May 8, 2018 · Vol. 9, No. 35 · pp. 24140-24154

Phase I dose-escalation study of F50067, a humanized anti-CXCR4 monoclonal antibody alone and in combination with lenalidomide and low-dose dexamethasone, in relapsed or refractory multiple myeloma Research Paper

Guillemette Fouquet, StÃ©phanie Guidez, Valentine Richez, Anne-Marie Stoppa, Christophe Le Tourneau, Margaret Macro, CÃ©cile Gruchet, Arthur Bobin, Niels Moya, Thomas Systchenko, Florence Sabirou, Anthony Levy, Paul Franques, HÃ©lÃ¨ne Gardeney, Lionel Karlin, Lotfi Benboubker, Monia Ouali, Jean-Claude Vedovato, Pierre Ferre, Mariya Pavlyuk, Michel Attal, Thierry Facon, Xavier Leleu

Published May 8, 2018 · Vol. 9, No. 35 · pp. 23890-23899

Stromal cells in breast cancer as a potential therapeutic target Review

Samantha S. Dykes, Veronica S. Hughes, Jennifer M. Wiggins, Henrietta O. Fasanya, Mai Tanaka, Dietmar Siemann

Published May 4, 2018 · Vol. 9, No. 34 · pp. 23761-23779

The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells Research Paper

Sabrina Dâ€™Agostino, Delia Lanzillotta, Mariaconcetta Varano, Cirino Botta, Antonio Baldrini, Anna Bilotta, Stefania Scalise, Vincenzo Dattilo, Rosario Amato, Eugenio Gaudio, Francesco Paduano, Camillo Palmieri, Rodolfo Iuliano, Nicola Perrotti, Cesare Indiveri, Alfredo Fusco, Marco Gaspari, Francesco Trapasso

Published May 4, 2018 · Vol. 9, No. 34 · pp. 23334-23348

Antitumoral and antimetastatic activity of Maitake D-Fraction in triple-negative breast cancer cells Research Paper

Eliana Noelia Alonso, MarÃa Julia Ferronato, MarÃa Eugenia Fermento, Norberto Ariel Gandini, Alejandro LÃ³pez Romero, Josefina Alejandra Guevara, MarÃa Marta Facchinetti, Alejandro Carlos Curino

Published May 4, 2018 · Vol. 9, No. 34 · pp. 23396-23412

Oxaliplatin-induced blood brain barrier loosening: a new point of view on chemotherapy-induced neurotoxicity Research Paper

Jacopo Junio Valerio Branca, Mario Maresca, Gabriele Morucci, Matteo Becatti, Ferdinando Paternostro, Massimo Gulisano, Carla Ghelardini, Daniela Salvemini, Lorenzo Di Cesare Mannelli, Alessandra Pacini

Published May 4, 2018 · Vol. 9, No. 34 · pp. 23426-23438

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

PHLDA2 is a key oncogene-induced negative feedback inhibitor of EGFR/ErbB2 signaling via interference with AKT signaling Research Paper

Aberration hubs in protein interaction networks highlight actionable targets in cancer Research Paper

High salt induces P-glycoprotein mediated treatment resistance in breast cancer cells through store operated calcium influx Research Paper

Large set data mining reveals overexpressed GPCRs in prostate and breast cancer: potential for active targeting with engineered anti-cancer nanomedicines Research Paper

Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer Research Paper

Combined mTOR and MEK inhibition is an effective therapy in a novel mouse model for angiosarcoma Research Paper

Potentiation of ¹⁷⁷Lu-octreotate peptide receptor radionuclide therapy of human neuroendocrine tumor cells by PARP inhibitor Research Paper

Regulatory role of resveratrol, a microRNA-controlling compound, in HNRNPA1 expression, which is associated with poor prognosis in breast cancer Research Paper

⁸⁹Zr-labeled CEA-targeted IL-2 variant immunocytokine in patients with solid tumors: CEA-mediated tumor accumulation and role of IL-2 receptor-binding Research Paper

A novel liver metastasis-correlated protein of pancreatic neuroendocrine neoplasm (PanNEN) discovered by proteomic analysis Research Paper

Pivotal role of human stearoyl-CoA desaturases (SCD1 and 5) in breast cancer progression: oleic acid-based effect of SCD1 on cell migration and a novel pro-cell survival role for SCD5 Research Paper

Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancer Research Paper

Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma Research Paper

Apatinib as targeted therapy for sarcoma Review

Genome-wide multi-omics profiling of the 8p11-p12 amplicon in breast carcinoma Research Paper

Phase I dose-escalation study of F50067, a humanized anti-CXCR4 monoclonal antibody alone and in combination with lenalidomide and low-dose dexamethasone, in relapsed or refractory multiple myeloma Research Paper

Stromal cells in breast cancer as a potential therapeutic target Review

The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells Research Paper

Antitumoral and antimetastatic activity of Maitake D-Fraction in triple-negative breast cancer cells Research Paper

Oxaliplatin-induced blood brain barrier loosening: a new point of view on chemotherapy-induced neurotoxicity Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

PHLDA2 is a key oncogene-induced negative feedback inhibitor of EGFR/ErbB2 signaling via interference with AKT signaling Research Paper

Aberration hubs in protein interaction networks highlight actionable targets in cancer Research Paper

High salt induces P-glycoprotein mediated treatment resistance in breast cancer cells through store operated calcium influx Research Paper

Large set data mining reveals overexpressed GPCRs in prostate and breast cancer: potential for active targeting with engineered anti-cancer nanomedicines Research Paper

Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer Research Paper

Combined mTOR and MEK inhibition is an effective therapy in a novel mouse model for angiosarcoma Research Paper

Potentiation of 177Lu-octreotate peptide receptor radionuclide therapy of human neuroendocrine tumor cells by PARP inhibitor Research Paper

Regulatory role of resveratrol, a microRNA-controlling compound, in HNRNPA1 expression, which is associated with poor prognosis in breast cancer Research Paper

89Zr-labeled CEA-targeted IL-2 variant immunocytokine in patients with solid tumors: CEA-mediated tumor accumulation and role of IL-2 receptor-binding Research Paper

A novel liver metastasis-correlated protein of pancreatic neuroendocrine neoplasm (PanNEN) discovered by proteomic analysis Research Paper

Pivotal role of human stearoyl-CoA desaturases (SCD1 and 5) in breast cancer progression: oleic acid-based effect of SCD1 on cell migration and a novel pro-cell survival role for SCD5 Research Paper

Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancer Research Paper

Three-lncRNA signature is a potential prognostic biomarker for pancreatic adenocarcinoma Research Paper

Apatinib as targeted therapy for sarcoma Review

Genome-wide multi-omics profiling of the 8p11-p12 amplicon in breast carcinoma Research Paper

Phase I dose-escalation study of F50067, a humanized anti-CXCR4 monoclonal antibody alone and in combination with lenalidomide and low-dose dexamethasone, in relapsed or refractory multiple myeloma Research Paper

Stromal cells in breast cancer as a potential therapeutic target Review

The receptor protein tyrosine phosphatase PTPRJ negatively modulates the CD98hc oncoprotein in lung cancer cells Research Paper

Antitumoral and antimetastatic activity of Maitake D-Fraction in triple-negative breast cancer cells Research Paper

Oxaliplatin-induced blood brain barrier loosening: a new point of view on chemotherapy-induced neurotoxicity Research Paper

Potentiation of ¹⁷⁷Lu-octreotate peptide receptor radionuclide therapy of human neuroendocrine tumor cells by PARP inhibitor Research Paper

⁸⁹Zr-labeled CEA-targeted IL-2 variant immunocytokine in patients with solid tumors: CEA-mediated tumor accumulation and role of IL-2 receptor-binding Research Paper